Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 804 results for "hodgkin"

Eric Berry of Kansas City Chiefs diagnosed with Hodgkin's lymphoma
ESPN.com

Eric Berry, NFL player, diagnosed with Hodgkin lymphoma

ATLANTA, Dec. 8 (UPI) -- Kansas City Chiefs safety Eric Berry was diagnosed with Hodgkin lymphoma after medical testing in Atlanta. Doctors suspected Berry might have the disease as early as Dec. 1, when the team placed him on the non-football ... UPI, 1 week ago
[x]  

161 images for hodgkin

Portland Press Herald, 6 days ago
Central Maine, 1 week ago
Irish Times, 1 week ago
Waterbury Republican American, 1 day ago
Cancernetwork.com, 1 week ago
101thefox.net, 1 week ago
Topeka Capital-Journal, 1 week ago
Business 2 Community, 1 week ago
101thefox.net, 1 week ago
Yard Barker, 1 week ago

The Future of Hodgkin Lymphoma -- Brentuximab and Beyond

Still Room for Improvement in Hodgkin Lymphoma Bruce D. Cheson, MD: This is Bruce Cheson, deputy chief of hematology and oncology and head of hematology at Georgetown University Hospital and Lombardi Comprehensive Cancer Center in Washington, DC.
 General Medicine eJournal3 days ago Double-Hit Lymphomas Explained, With Surprising EPOCH-R Data  Medscape5 days ago

Merck announces favorable data from classical Hodgkin lymphoma study

Merck has announced study findings demonstrating that KEYTRUDA, or pembrolizumab, the company's anti-PD-1 therapy, achieved an overall response rate of 66%, as assessed by International Harmonization Project response criteria, in ...
 Individual.com4 days ago Data Investigating KEYTRUDA® (pembrolizumab), Merck's Anti-PD-1 Therapy, in Patients with Classical Hodgkin Lymphoma Presented at ASH Annual Meeting  Noodls5 days ago
UnitedHealthcare

PD-1 Immunotherapy Shows Promise in Hodgkin's Lymphoma

CancerConnect News: The cancer immunotherapy strategy known as programmed cell death 1 (PD-1) has generated great excitement for its ability to help the immune system recognize and attack cancer. Now according to researcher recently published in The ...
 CancerConnect.com3 days ago New drugs show promise in fighting Hodgkins lymphoma  UnitedHealthcare1 week ago New Hodgkin Lymphoma Drug Shows Promise  RTTNews.com1 week ago 'Breakthrough' immunotherapy drug fights Hodgkin lymphoma  News.am1 week ago
[x]  

Janssen Biotech plans to initiate Phase II non-Hodgkin's lymphoma study

Genmab A/S, a biotechnology company, has announced that its collaboration partner, Janssen Biotech, Inc. has planned to start a Phase II study of daratumumab in non-Hodgkin's lymphomas, or NHL. The study (LYM2001) will evaluate daratumumab ...
 Individual.com6 days ago Marina Biotech, Inc., Ink $50 Million R&D Pact  BioSpace3 days ago Marina Biotech, Inc. (MRNA: OTCQB) | Marina Biotech and MiNA Therapeutics Announce License Agreement for the Development of saRNA-Based Therapeutics  Pink Sheets3 days ago Marina Biotech : and MiNA Therapeutics Announce License Agreement for the Development of saRNA-Based Therapeutics  4 Traders3 days ago
[x]  
USA Today

UPS hopes for a merrier Christmas in 2014

HODGKINS, Ill. — This holiday season, UPS insists it is ready. After facing an avalanche of criticism last year for failing to deliver thousands of packages by Christmas Eve, the shipping company says it's well-prepared to make this a merrier ...
 USA Today6 days ago

Non-Hodgkin Lymphoma- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

Summary '', report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understanding for API Manufacturers for marketed and Phase III pipeline ...
 Individual.com1 week ago Hodgkin Lymphoma- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014  Individual.com1 week ago

Takeda Pharmaceuticals develops new Hodgkin lymphoma drug

Takeda UK Ltd has published data suggesting that Hodgkin lymphoma patients at risk of relapse following an autologous stem cell transplant, and who receive ADCETRIS (brentuximab vedotin) as consolidation therapy immediately after ASCT had a ...
 Pharma Field1 week ago Hodgkin lymphoma: Phase 3 AETHERA clinical trial data reported  Medical News Today1 week ago

Bristol-Myers Posts Positive Opdivo Hodgkin Lymphoma Data

Bristol-Myers Squibb Company ( BMY ) announced encouraging data from the ongoing phase Ib CheckMate - 039 study on immuno-oncology drug Opdivo (nivolumab, a PD-1 immune checkpoint inhibitor). Data from the study was published in The New England ...
 Yahoo! Finance1 week ago Bristol-Myers Squibb Company, Merck & Co. Drugs Effective In Hodgkin Lymphoma Trials  BioSpace1 week ago

Vee Pak's New Website Offers Customers Enhanced Graphics and Capabilities Data

Vee Pak, Inc., is proud to announce the recent launch of its new website: http://www.veepak.com Hodgkins, IL (PRWEB) December 17, 2014 Vee Pak, Inc., is proud to announce the recent launch of its new website: http://www.veepak.com .
 MySanAntonio3 days ago Vee Paks New Website Offers Customers Enhanced Graphics and Capabilities Data  Review Seeker4 days ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less